Product Details
Clavulin
Amoxicillin + Clavulanic Acid25 mg + 6.25 mg/mL
Powder for Oral Suspension
DIN/PIN/NPN
01916882
Manufacturer
GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care
Formulary Listing Date
1996-10-01
Unit Price
0.1173
Amount MOH Pays
0.1173
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Amoxicillin + Clavulanic Acid: Amoxicillin/clavulanic acid is not recommended as first line treatment for acute otitis media and sinusitis. Antibiotic resistance (H. influenzae, M. catarrhalis) due to B-lactamase production has caused only a minority of treatment failures with amoxicillin. Amoxicillin/clavulanic acid is first line treatment for infected bites of cat, dog or human.
ATC Code
J01CR02